Literature DB >> 23333222

A sulfated glycosaminoglycan array for molecular interactions between glycosaminoglycans and growth factors or anti-glycosaminoglycan antibodies.

Wataru Takada1, Masao Fukushima, Peraphan Pothacharoen, Prachya Kongtawelert, Kazuyuki Sugahara.   

Abstract

Glycosaminoglycans (GAGs) take part in numerous biological processes by binding to protein molecules and functionally regulating protein-ligand interactions; therefore, molecular interactions of GAGs have been studied by several methods, including surface plasmon resonance, enzyme-linked immunosorbent assays (ELISAs), and GAG microarrays. To achieve rapid, sensitive, and high-throughput screening of GAG interactions, we have developed a novel microarray in which GAGs, including chondroitin sulfate, heparan sulfate, and heparin, were immobilized. The microarray is made from cyclic polyolefin substrate coated with metacrylate polymers, which have phospholipid groups as side chains. The polymer also has aminooxy groups that react specifically with aldehyde groups at the reducing termini of GAG chains, whereas the phospholipid groups prevent nonspecific adsorption of proteins. Thus, minute amounts of GAGs can be chemically immobilized on the surface with low nonspecific binding of proteins. Using this array, interactions between GAGs and antibodies against chondroitin or heparan sulfate and heparin-binding growth factors were examined. The results were in agreement with previously reported specificities, suggesting that the GAG array is useful for high-throughput interaction analyses between GAGs and functional proteins in miniscule amounts and can be applied to both basic studies of GAGs and the development of diagnostic methods for metabolic diseases involving GAGs.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333222     DOI: 10.1016/j.ab.2013.01.004

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

Review 1.  Glycosaminoglycanomics: where we are.

Authors:  Sylvie Ricard-Blum; Frédérique Lisacek
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

Review 2.  The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome.

Authors:  Angelina S Palma; Ten Feizi; Robert A Childs; Wengang Chai; Yan Liu
Journal:  Curr Opin Chem Biol       Date:  2014-02-07       Impact factor: 8.822

3.  HIF-miR-215-KDM1B promotes glioma-initiating cell adaptation to hypoxia.

Authors:  Jing Hu; Xiao-Fan Wang
Journal:  Cell Cycle       Date:  2016-05-10       Impact factor: 4.534

4.  Gliding Motility of Mycoplasma mobile on Uniform Oligosaccharides.

Authors:  Taishi Kasai; Tasuku Hamaguchi; Makoto Miyata
Journal:  J Bacteriol       Date:  2015-07-06       Impact factor: 3.490

5.  A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E.

Authors:  Tomoko Watanabe; Ko Takeda; Keiko Hiemori; Toshikazu Minamisawa; Hiroaki Tateno
Journal:  FEBS Lett       Date:  2021-08-17       Impact factor: 3.864

Review 6.  Glycosaminoglycans in biomedicine.

Authors:  Rebecca A Scott; Alyssa Panitch
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-04-18

7.  MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B.

Authors:  Jing Hu; Tao Sun; Hui Wang; Zhengxin Chen; Shuai Wang; Lifeng Yuan; Tingyu Liu; Hai-Ri Li; Pingping Wang; Yukuan Feng; Qinhong Wang; Roger E McLendon; Allan H Friedman; Stephen T Keir; Darell D Bigner; Jeff Rathmell; Xiang-Dong Fu; Qi-Jing Li; Huibo Wang; Xiao-Fan Wang
Journal:  Cancer Cell       Date:  2016-01-11       Impact factor: 31.743

8.  A versatile salt-based method to immobilize glycosaminoglycans and create growth factor gradients.

Authors:  Danique J Hof; Elly M M Versteeg; Chris H A van de Lest; Willeke F Daamen; Toin H van Kuppevelt
Journal:  Glycoconj J       Date:  2019-05-04       Impact factor: 2.916

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.